Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I’ve been tracking the same thing. Those 'operational excellence' emails are a massive red flag. When roles vanish from the portal without a word, it’s rarely a technical glitch—it’s a budget freeze dressed up as corporate efficiency. I’m in the same boat, seeing projects get shelved and headcount essentially locked down. At this point, I’m just preparing for the worst and keeping my resume updated, because management never admits to a hiring freeze until they’re already halfway through the layoffs.
Honestly, don't hold your breath for any transparency. Biogen has a long history of these 'streamlining' phases that end in quiet exits. If the portal is dead, it’s dead for a reason. The Q3 targets are clearly putting immense pressure on leadership to cut costs fast, and R&D is always the first place they look when they need to balance the books for the shareholders. It’s stressful, but try not to let the silence get to you—just focus on your own pivot if things don't look better by next month.